Now showing items 1-1 of 1

    • Biologics and Biosimilars as Treatment Options for Psoriasis 

      Moya, Amena Khatun (Brac University, 2022-02)
      Psoriasis is a common chronic skin disease stemming from a systemic inflammatory disorder. It affects more than 7.5 million people in the United States and an estimated 125 million people worldwide. It is an immune-mediated ...